News for hackers. Stuff that matters.
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by m12k on Friday January 29, 2021 @05:00PM (#25963258)
I originally thought the Oxford/AstraZeneca vaccine was significantly behind the mRNA vaccines in efficacy. But then I learned that the Oxford trials PCR-tested every participant regularly, while the Pfizer and Moderna trials only tested participants that were showing symptoms. So there's a very real chance that behind that ~95% number the mRNA vaccines also had asymptomatic cases that were never discovered during trials, and the actual protection is nearly the same as the Oxford one. The mRNA vaccines still seem like a great leap forward, and they don't come with the potential complications of resistance to the vector virus that adenovirus-based vaccines do - but I'm less sure now that they actually offer better protection overall.
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by mlyle on Friday January 29, 2021 @10:00PM (#25965589)
No. AstraZeneca also tested with weekly PCR surveillance. But the efficacy numbers we're comparing between AstraZeneca and the mRNA vaccines are measures of how often they prevents symptomatic illness-- a very similar standard to that used in the Moderna and Pfizer trials (but not absolutely, directly comparable).

Unfortunately, the AZ trial is a mess. One way it was a mess is that the error bars on how much they prevent all illness (not just symptomatic illness) go all the way down to 1%.

Re:Johnson and Johnson single-shot vaccine appears 66% effec... by tpmx on Friday January 29, 2021 @05:07PM (#25963336)
> But then I learned that the Oxford trials PCR-tested every participant regularly, while the Pfizer and Moderna trials only tested participants that were showing symptoms.

That seems substantial, weird and important. Source?

Re:Johnson and Johnson single-shot vaccine appears 66% effec... by jepler on Friday January 29, 2021 @06:27PM (#25964211)
I found this document https://www.astrazeneca.com/media-centre/press-releases/2020... which stated about the phase I/II trial that "Weekly COVID-19 PCR testing is performed". However, the phase II/III and phase III trials state "Suspected cases presenting with compatible symptoms were tested for virological confirmation by COVID-19 PCR" (slightly different wording in the two cases)
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by m-ee on Friday January 29, 2021 @05:39PM (#25963713)
They did do more PCR but that isn’t reflected in the efficacy numbers. The end point for all trials has been prevention of symptomatic disease.
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by tpmx on Friday January 29, 2021 @05:40PM (#25963732)
And where is your source for that?
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by m-ee on Friday January 29, 2021 @05:47PM (#25963805)
It's quite literally one of the first things mentioned in the trial protocols and journal articles

https://clinicaltrials.gov/ct2/show/NCT04516746

"The efficacy of 2 IM doses of AZD1222 compared to placebo for the prevention of COVID-19 in adults ≥ 18 years of age [ Time Frame: 1 year ]

A binary response, whereby a participant is defined as a COVID-19 case if their first case of SARS-CoV-2 RT-PCR-positive symptomatic illness occurs

≥ 15 days post second dose of study intervention. Otherwise, a participant is not defined as a COVID-19 case."

https://www.thelancet.com/journals/lancet/article/PIIS0140-6...

"The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. "

Re:Johnson and Johnson single-shot vaccine appears 66% effec... by m12k on Friday January 29, 2021 @06:38PM (#25964325)
I think you're right, now that I know what to look for. The AZ/Oxford vaccine has lower symptomatic efficacy than the mRNA ones, and it's asymptomatic efficacy is lower still. We don't know what the asymptomatic efficacy of the mRNA vaccines is yet, but since their symptomatic efficacy is higher, it would be reasonable to expect their asymptomatic efficacy to also be higher.

So at the end of the day, the main question regarding the AZ/Oxford vaccine is whether a half-dose starter shot regimen, or longer time between doses can bring its efficacy more consistently up around 90%, which would make it only slightly less effective than the mRNA ones, or if it's efficacy is actually just lower.

Re:Johnson and Johnson single-shot vaccine appears 66% effec... by m-ee on Friday January 29, 2021 @07:11PM (#25964595)
The half dose and longer time efficacy numbers have confidence intervals around 50-60% wide, definitely need to do more testing on that. I agree its the biggest question to answer for them (aside from just getting cleaner data through the US trial that will hopefully report soon). I believe they were also doing a study with mixed doses of Oxford/Sputnik.
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by kelnos on Friday January 29, 2021 @07:57PM (#25964877)
The links you provided seem to be for AstraZenica's vaccine, though, not for Moderna's or Pfizer's (which is what 'm12k was originally talking about). That seems to suggest that Oxford/AZN were only testing symptomatic trial participants, no? And says nothing about what Moderna or Pfizer were doing?
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by m-ee on Saturday January 30, 2021 @01:07AM (#25966668)
Moderna and Pfizer/Biontech did not do regular screening to check for asymptomatic cases, aside from some samples taken in between the shots. Oxford/AZ did regularly screen some participants, but the primary efficacy analysis only looked at symptomatic cases similar to the mRNA vaccines.
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by kelnos on Saturday January 30, 2021 @01:40AM (#25966833)
Ok, but the question in the thread was about sources showing that Moderna & Pfizer did not do regular screening; seems like no one had found that info earlier, but I now see someone downthread has posted more about this.
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by m12k on Friday January 29, 2021 @06:04PM (#25963989)
Oxford:

https://www.thelancet.com/journals/lancet/article/PIIS0140-6...

"To test for asymptomatic infections, participants in COV002 in the UK were asked to provide a weekly self-administered nose and throat swab for NAAT testing from 1 week after first vaccination using kits provided by the UK Department of Health and Social Care (DHSC)"

Moderna:

https://www.nih.gov/news-events/news-releases/phase-3-clinic... "Investigators will closely monitor participant safety. They will call participants after each vaccination to discuss any symptoms and will provide participants with a diary to record symptoms and a thermometer for temperature readings. If a participant is suspected to have COVID-19, the participant will be asked to provide a nasal swab for testing within 72 hours."

https://www.nejm.org/doi/10.1056/NEJMoa2035389 "although our trial showed that mRNA-1273 reduces the incidence of symptomatic SARS-CoV-2 infection, the data were not sufficient to assess asymptomatic infection, although our results from a preliminary exploratory analysis suggest that some degree of prevention may be afforded after the first dose"

Pfizer:

https://www.sciencemediacentre.org/expert-reaction-to-phase-... "The Pfizer study did not report studies of the impact of its vaccine on asymptomatic infection. The Oxford study reported that efficacy for “asymptomatic or symptoms unknown infection” based on weekly self-swabbing was 3·8% (−72·4 to 46·3%) following standard dose and 58·9% (95% CI 1·0 to 82·9) following low dose regimen."

https://www.nejm.org/doi/10.1056/NEJMoa2034577 "These data do not address whether vaccination prevents asymptomatic infection; a serologic end point that can detect a history of infection regardless of whether symptoms were present (SARS-CoV-2 N-binding antibody) will be reported later"

PS: Sorry, but it took a little while to dig up original sources to random news articles I'd read months earlier

Re:Johnson and Johnson single-shot vaccine appears 66% effec... by tpmx on Friday January 29, 2021 @06:16PM (#25964100)
I owe you an excuse (I'm sorry), I think you are indeed correct - there seems to be a marked difference between the protocols.
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by andybak on Friday January 29, 2021 @06:44PM (#25964373)
I'd also point out that "not replying in 1 hour" is a very high bar. HN doesn't give notifications of thread replies, I don't know what timezone that person was in and people have real lives that take priority over forum discussions.

I sometimes post something here and completely forget to look for replies. I'd hate to come back a week later to find out I'd been vilified for it.

Re:Johnson and Johnson single-shot vaccine appears 66% effec... by tpmx on Friday January 29, 2021 @06:52PM (#25964435)
> I'd also point out that "not replying in 1 hour" is a very high bar.

Where did you get that from?

Re:Johnson and Johnson single-shot vaccine appears 66% effec... by andybak on Friday January 29, 2021 @07:05PM (#25964553)
Apologies if I got it wrong but I thought you made a comment (later deleted) along the lines of "you've made a strong claim and 1 hour later still haven't provided evidence".

Because it was deleted I can't check if it was you or not. I had it open in a tab and it disappeared when I refreshed.

Re:Johnson and Johnson single-shot vaccine appears 66% effec... by M2Ys4U on Friday January 29, 2021 @05:45PM (#25963784)
"Unlike other vaccines being trialled, the Oxford team had been taking weekly swabs from all volunteers to check whether they were infected but showing no symptoms."

https://www.bbc.co.uk/news/health-55308216

Re:Johnson and Johnson single-shot vaccine appears 66% effec... by m-ee on Friday January 29, 2021 @05:48PM (#25963813)
This does not mean that this is reflected in the efficacy numbers. Read the paper and protocols they very clearly specify symptomatic disease confirmed with PCR.
Re:Johnson and Johnson single-shot vaccine appears 66% effec... by benrapscallion on Saturday January 30, 2021 @09:20AM (#25969268)
One must also take into account the fact that when the Moderna and Pfizer vaccines were tested, the South African, U.K., and Brazilian variants didn’t exist. In the J&J trial they were dominant. As a result they are not comparable. The J&J vaccine had 0 cases of severe disease in the treatment arm and that really is the statistic one is looking for.[1]

[1] https://twitter.com/chrislhayes/status/1355352505987854340